tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market
RARE
Ultragenyx Pharmaceutical
RESEARCH TOOLSreports

Ultragenyx Pharmaceutical (RARE) Balance Sheet

1,217 Followers

Ultragenyx Pharmaceutical Balance Sheet

Ultragenyx Pharmaceutical's total assets for Q4 2025 were $1.53B, an increase of 28.69% from the previous quarter. RARE total liabilities were $1.60B for the fiscal quarter, a 36.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.53B$ 1.50B$ 1.49B$ 1.55B$ 1.52B
Total Liabilities
$ 1.60B$ 1.24B$ 1.22B$ 1.19B$ 599.84M
Total Equity Gross Minority
$ -73.00M$ 262.30M$ 275.41M$ 352.49M$ 922.56M
Other Metrics
Currency in USD

Ultragenyx Pharmaceutical Debt to Assets